parlodel 2.5 mg tablet
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - bromocriptine (as mesylate) - tablet - 2.5 mg
parlodel cap 5mg capsule
novartis pharmaceuticals canada inc - bromocriptine (bromocriptine mesylate) - capsule - 5mg - bromocriptine (bromocriptine mesylate) 5mg - ergot-derivative dopamine receptor agonists
parlodel 2.5 mg tabl.
viatris healthcare sa-nv - bromocriptine mesilate 2,87 mg - eq. bromocriptine 2,5 mg - tablet - 2,5 mg - bromocriptine mesilate 2.87 mg - bromocriptine
parlodel 10 mg hard caps.
viatris healthcare sa-nv - bromocriptine mesilate 11,47 mg - eq. bromocriptine 10 mg - capsule, hard - 10 mg - bromocriptine mesilate 11.47 mg - bromocriptine
parlodel 5 mg hard caps.
viatris healthcare sa-nv - bromocriptine mesilate 5,74 mg - eq. bromocriptine 5 mg - capsule, hard - 5 mg - bromocriptine mesilate 5.74 mg - bromocriptine
parlodel tablets 2.5mg
meditpharma ltd 71, triq karmenu camilleri, qormi qrm 4631, malta - bromocriptine - tablet - bromocriptine 2.5 mg - anti-parkinson drugs
parlodel 2.5 mg tab tablet
novartis - bromocriptine - tablet - 2.5 mg
parlodel 2.5 mg tab tablet
novartis pharma ag, switzerland - bromocriptine - tablet - 2.5 mg
parlodel 2,5 mg tablet
sandoz south africa (pty) ltd - tablet - see ingredients - each tablet contains bromocriptine 2,5 mg
parlodel 5 mg capsule
novartis south africa (pty) ltd - capsule - each capsule contains bromocriptine mesylate equivalent to 5 mg bromocriptine